95 related articles for article (PubMed ID: 18203022)
41. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
Christodoulopoulos G; Malapetsa A; Schipper H; Golub E; Radding C; Panasci LC
Clin Cancer Res; 1999 Aug; 5(8):2178-84. PubMed ID: 10473103
[TBL] [Abstract][Full Text] [Related]
42. Effects of XRCC2 and RAD51B mutations on somatic and meiotic recombination in Arabidopsis thaliana.
Da Ines O; Degroote F; Amiard S; Goubely C; Gallego ME; White CI
Plant J; 2013 Jun; 74(6):959-70. PubMed ID: 23521529
[TBL] [Abstract][Full Text] [Related]
43. Causation of chronic lymphocytic leukemia--insights from familial disease.
Houlston RS; Sellick G; Yuille M; Matutes E; Catovsky D
Leuk Res; 2003 Oct; 27(10):871-6. PubMed ID: 12860003
[TBL] [Abstract][Full Text] [Related]
44. RAD51AP1 and RAD54L Can Underpin Two Distinct RAD51-Dependent Routes of DNA Damage Repair
Selemenakis P; Sharma N; Uhrig ME; Katz J; Kwon Y; Sung P; Wiese C
Front Cell Dev Biol; 2022; 10():866601. PubMed ID: 35652094
[TBL] [Abstract][Full Text] [Related]
45. Familial chronic lymphocytic leukemia.
Houlston RS; Catovsky D
Curr Hematol Malig Rep; 2008 Oct; 3(4):221-5. PubMed ID: 20425469
[TBL] [Abstract][Full Text] [Related]
46. Identification of a novel heterozygous germline RAD52 missense mutation in a patient with gallbladder carcinoma: A case report.
Zhao W; Dai Y; Yue L; Gu J; Meng E; Wang D; Liu S; Han X; Wang X; Li G; Dai X
Medicine (Baltimore); 2021 May; 100(19):e25957. PubMed ID: 34106670
[TBL] [Abstract][Full Text] [Related]
47. Utilization of Rad51C promoter for transcriptional targeting of cancer cells.
Cao Y; Xu Y; Zhang L; Li Z; Jiang Y; Tian X; Seluanov A; Gorbunova V; Mao Z
Oncotarget; 2014 Apr; 5(7):1805-11. PubMed ID: 24742710
[TBL] [Abstract][Full Text] [Related]
48. Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination.
Setton J; Selenica P; Mukherjee S; Shah R; Pecorari I; McMillan B; Pei IX; Kemel Y; Ceyhan-Birsoy O; Sheehan M; Tkachuk K; Brown DN; Zhang L; Cadoo K; Powell S; Weigelt B; Robson M; Riaz N; Offit K; Reis-Filho JS; Mandelker D
NPJ Breast Cancer; 2021 Oct; 7(1):135. PubMed ID: 34635660
[TBL] [Abstract][Full Text] [Related]
49. The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution.
Mosquera Orgueira A; Antelo Rodríguez B; Alonso Vence N; Díaz Arias JÁ; Díaz Varela N; Pérez Encinas MM; Allegue Toscano C; Goiricelaya Seco EM; Carracedo Álvarez Á; Bello López JL
BMC Cancer; 2019 May; 19(1):515. PubMed ID: 31142279
[TBL] [Abstract][Full Text] [Related]
50. Inherited susceptibility to CLL.
Speedy HE; Sava G; Houlston RS
Adv Exp Med Biol; 2013; 792():293-308. PubMed ID: 24014302
[TBL] [Abstract][Full Text] [Related]
51. Rare germline variants in ATM are associated with chronic lymphocytic leukemia.
Tiao G; Improgo MR; Kasar S; Poh W; Kamburov A; Landau DA; Tausch E; Taylor-Weiner A; Cibulskis C; Bahl S; Fernandes SM; Hoang K; Rheinbay E; Kim HT; Bahlo J; Robrecht S; Fischer K; Hallek M; Gabriel S; Lander ES; Stilgenbauer S; Wu CJ; Kiezun A; Getz G; Brown JR
Leukemia; 2017 Oct; 31(10):2244-2247. PubMed ID: 28652578
[No Abstract] [Full Text] [Related]
52. Candidate gene association studies and risk of chronic lymphocytic leukemia: a systematic review and meta-analysis.
Sava GP; Speedy HE; Houlston RS
Leuk Lymphoma; 2014 Jan; 55(1):160-7. PubMed ID: 23647060
[TBL] [Abstract][Full Text] [Related]
53. [Research Advances of RAD51AP1 in Tumor Progression and Drug Resistance].
Liu R; Li M; Hu Z; Song Z; Chen J
Zhongguo Fei Ai Za Zhi; 2023 Sep; 26(9):701-708. PubMed ID: 37985156
[TBL] [Abstract][Full Text] [Related]
54. SAMHD1: a new gene for CLL.
Rossi D
Blood; 2014 Feb; 123(7):951-2. PubMed ID: 24526775
[No Abstract] [Full Text] [Related]
55. Whole exome sequencing in families with CLL detects a variant in Integrin β 2 associated with disease susceptibility.
Goldin LR; McMaster ML; Rotunno M; Herman SE; Jones K; Zhu B; Boland J; Burdett L; Hicks B; Ravichandran S; Luke BT; Yeager M; Fontaine L; Goldstein AM; Chanock SJ; Tucker MA; Wiestner A; Marti G; Caporaso NE
Blood; 2016 Nov; 128(18):2261-2263. PubMed ID: 27629550
[No Abstract] [Full Text] [Related]
56. Looking for CLL genes.
Jønsson V; Samuelsen SO; Tjønnfjord G; Johannesen T
Leuk Lymphoma; 2008 Jan; 49(1):10-1. PubMed ID: 18203003
[No Abstract] [Full Text] [Related]
57. Inherited susceptibility to chronic lymphocytic leukemia: the good candidates.
Rossi D
Leuk Lymphoma; 2014 Jan; 55(1):9-10. PubMed ID: 23734657
[No Abstract] [Full Text] [Related]
58. RAD51B Activity and Cell Cycle Regulation in Response to DNA Damage in Breast Cancer Cell Lines.
Lee PS; Fang J; Jessop L; Myers T; Raj P; Hu N; Wang C; Taylor PR; Wang J; Khan J; Jasin M; Chanock SJ
Breast Cancer (Auckl); 2014; 8():135-44. PubMed ID: 25368520
[TBL] [Abstract][Full Text] [Related]
59. Clinical and immunophenotypic characteristics of familial leukemia predisposition caused by PAX5 germline variants.
Escudero A; Takagi M; Auer F; Friedrich UA; Miyamoto S; Ogawa A; Imai K; Pascual B; Vela M; Stepensky P; Yasin L; Elitzur S; Borkhardt A; Pérez-Martínez A; Hauer J
Leukemia; 2022 Sep; 36(9):2338-2342. PubMed ID: 35902733
[No Abstract] [Full Text] [Related]
60. In Silico-Based Structural Evaluation to Categorize the Pathogenicity of Mutations Identified in the RAD Class of Proteins.
Anwaar A; Varma AK; Baruah R
ACS Omega; 2023 Mar; 8(11):10266-10277. PubMed ID: 36969410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
